Brokerages Set agilon health, inc. (NYSE:AGL) Target Price at $4.79

agilon health, inc. (NYSE:AGL - Get Free Report) has received a consensus recommendation of "Hold" from the nineteen ratings firms that are covering the company, MarketBeat.com reports. Two analysts have rated the stock with a sell recommendation, twelve have issued a hold recommendation and five have issued a buy recommendation on the company. The average twelve-month target price among brokers that have covered the stock in the last year is $4.79.

Several research firms have recently weighed in on AGL. Wells Fargo & Company decreased their target price on agilon health from $6.00 to $5.00 and set an "overweight" rating on the stock in a research report on Tuesday, May 13th. JMP Securities restated a "market perform" rating on shares of agilon health in a report on Monday, April 28th. Stifel Nicolaus upped their target price on shares of agilon health from $2.00 to $3.00 and gave the stock a "hold" rating in a report on Wednesday, February 26th. Citigroup upgraded shares of agilon health from a "neutral" rating to a "buy" rating and increased their target price for the company from $3.25 to $5.00 in a research report on Friday, April 25th. Finally, TD Cowen boosted their price target on shares of agilon health from $3.50 to $6.00 and gave the stock a "hold" rating in a research report on Tuesday, April 15th.

Institutional Investors Weigh In On agilon health

Institutional investors and hedge funds have recently added to or reduced their stakes in the business. Ieq Capital LLC acquired a new stake in shares of agilon health during the 4th quarter worth about $26,000. Signaturefd LLC boosted its stake in agilon health by 143.0% during the fourth quarter. Signaturefd LLC now owns 14,388 shares of the company's stock worth $27,000 after buying an additional 8,467 shares during the period. Humankind Investments LLC acquired a new stake in shares of agilon health during the fourth quarter valued at about $30,000. Raymond James Financial Inc. purchased a new stake in shares of agilon health in the 4th quarter valued at approximately $33,000. Finally, Cerity Partners LLC purchased a new stake in shares of agilon health in the 4th quarter valued at approximately $34,000.

agilon health Price Performance

Shares of NYSE:AGL traded up $0.02 during midday trading on Friday, reaching $2.24. 4,518,475 shares of the company's stock traded hands, compared to its average volume of 4,949,950. The company has a fifty day simple moving average of $3.96 and a two-hundred day simple moving average of $3.18. agilon health has a 1 year low of $1.50 and a 1 year high of $7.73. The company has a market cap of $927.25 million, a P/E ratio of -2.38 and a beta of 0.38. The company has a debt-to-equity ratio of 0.06, a quick ratio of 1.29 and a current ratio of 1.29.

agilon health (NYSE:AGL - Get Free Report) last announced its earnings results on Tuesday, May 6th. The company reported $0.03 earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.01) by $0.04. agilon health had a negative net margin of 6.88% and a negative return on equity of 47.84%. The business had revenue of $1.53 billion for the quarter, compared to analyst estimates of $1.50 billion. During the same quarter last year, the business earned ($0.02) earnings per share. The company's revenue for the quarter was down 4.5% compared to the same quarter last year. Equities analysts predict that agilon health will post -0.59 EPS for the current fiscal year.

agilon health Company Profile

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.